The global contrast media market, valued at US$5.9 billion in 2022, is forecasted to grow at a robust CAGR of 7.5%, reaching US$6.3 billion in 2023 and an impressive US$9.7 billion by 2029.  The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Market growth is largely driven by rising number of hospitals and diagnostic imaging centers, awareness regarding early diagnosis and rising prevalence of chronic conditions. On the other hand, the adverse effects associated with the use of contrast media will restrain the growth of this market to a certain extent.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911

Browse in-depth TOC on "Contrast Media Market"

  • 253 - Tables
  • 41 - Figures
  • 278 - Pages
 

iodinated contrast media segment held the largest share of the contrast media market, by type segment.

Based on type, the global contrast media market is categorized into iodinated contrast media, gadolinium-based contrast media, microbubble contrast media, and barium-based contrast media. Iodinated contrast media account for the largest share of the contrast media market. The large share of this segment can be attributed to the growing number of procedures that require the use of iodinated contrast media, owing to benefits such as their versatility and their capacity to be used across multiple modalities such as X-ray and CT.

cardiovascular diseases segment held the largest share of the contrast media market, by indication segment.

By indication, the contrast media market has been segmented into cardiovascular diseases, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The large share of cardiovascular diseases indication is attributed to factors rising prevalence of CVD diseases across the globe, coupled with the rise in awareness regarding early diagnosis of diseases.

North America dominates the global contrast media market.

Based on the region, the contrast media market is segmented into North America, Europe, Asia Pacific, and Rest of the world. In 2022, North America accounted for the largest contrast media market share. The large share of the region in the global market can be attributed to the increasing prevalence of chronic conditions and rising healthcare spending. Moreover, presence of key players and number of developments undertaken are helping the region gain a reasonable share in the market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=911

Key Market Players of Contrast Media Industry:

The major players operating in this market are GE HealthCare (US), Bracco Imaging S.p.A. (Italy), Bayer AG (Germany), Guerbet (France), Lantheus Medical Imaging (US), Unijules Life Sciences Ltd. (India), JB Pharma (India), Sanochemia Pharmazeutika (Germany), TAEJOON PHARM Co., Ltd. (South Korea), Jodas Expoim (India), iMax Diagnostic Imaging Limited (Ireland), YZJ Group (China), Livealth Biopharma Pvt. Ltd. (India), Unispire Biopharma Private Limited (India), Acro Lifesciences (I) Pvt. Ltd. (India), Stanex Drugs & Chemical Pvt. Ltd. (India), Beijing Beilu Pharmaceutical Co., Ltd. (China), Rege Imaging & Cine Films Private Limited (India), K DIAM EXIM (India), Onko Ýlaç San. ve Tic. A.Þ. (Turkey), Fresenius Kabi (Germany), Biem Ilaç San. ve Tic. A.S. (Turkey), and AdvaCare (US).

The break-up of the profile of primary participants in the contrast media market:

  • By Company Type: Tier 1 - 35%, Tier 2 - 40%, and Tier 3 – 25%
  • By Designation: C-level - 45%, D-level - 29%, and Others - 26%
  • By Region: North America - 35%, Europe - 27%, Asia Pacific - 32%, Rest of the World- 6%

BAYER AG

Bayer held the leading position in the contrast media market in 2022. The company has a strong portfolio of MRI contrast agents and the upper hand in the MRI contrast market. The company recorded encouraging sales for its Gadovist MRI contrast agent, primarily due to the positive development of business in Europe. Gadovist is the first and only macrocyclic gadolinium-based contrast agent approved for magnetic resonance angiography (MRA) of the supra-aortic vasculature and breast MRI (BMR)

BRACCO IMAGING SPA

Bracco Imaging held the second position in the contrast media market in 2022. Bracco has a broad product portfolio in the X-ray and CT contrast media segment. The company markets its contrast media products directly or indirectly in over 100 markets. The company continuously strives to strengthen its market position by focusing on approvals for its contrast media products. Bracco also focuses on joint ventures to enhance its product capabilities and develop new products.

GE HEALTHCARE

GE HealthCare held the third position in the global contrast media market in 2022. GE HealthCare serves customers in more than 160 countries and has a strong distribution network across the Americas, Europe, the Pacific Basin, and the Middle East & Africa. GE HealthCare’s pharmaceutical segment has a strong foothold in the US, accounting for 44% of its total revenue. EMEA and China held shares of 26% and 14%, respectively. To maintain its leading position and meet growing customer requirements, the company has significantly expanded its contrast media production capacity.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=911

Contrast Media Market - Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall contrast media market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.